Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera
NCT01193699
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Polycythemia Vera
Interventions
DRUG:
PEG-P-INF alpha-2b (P1101)
Sponsor
AOP Orphan Pharmaceuticals AG